Market revenue in 2023 | USD 842.5 million |
Market revenue in 2030 | USD 1,591.4 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.39% in 2023. Horizon Databook has segmented the Germany stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has a large number of institutes and universities involved in stem cell research, thereby boosting revenue generation in this country. Moreover, conferences and workshops on human stem cell technology held in the region are expected to drive the regional market.
Although the country has strict laws and regulatory policies pertaining to stem cell research, the country encourages research in stem cells for clinical applications. AMESANAR is derived from allogeneic ABCB5-positive MSCs and will be produced by TICEBA GmbH from donor skin. Hence, it is one of the first somatic cell therapy based on skin validates to receive approval.
Advances in clinical applications of stem cell therapy along with growing preference for the therapy are expected to further influence the market growth. Increased adoption by the local population along with foreign patients visiting the country for stem cell therapies is anticipated to further boost the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Germany stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account